Compare iShares China Large-Cap ETF (FXI) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares China Large-Cap ETF vs Intuitive Surgical, Inc. — how do they compare? iShares China Large-Cap ETF trades at $34.25 (market cap $3.86B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 38× iShares China Large-Cap ETF's market cap, and iShares China Large-Cap ETF is more actively traded (16,323,837 versus 2,529,814). Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 150 Days and Intuitive Surgical, Inc. for 84 Days on average.
| FXI | ISRG | |
|---|---|---|
Market Cap | $3.86B | $146.76B |
Volume | 16,323,837 | 2,529,814 |
52-Week High | $41.08 | $592.85 |
52-Week Low | $31.59 | $332.02 |
Typical Hold Time | 150 Days | 84 Days |
Sector | — | Health |
Enterprise Value | — | $141.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FXI trades at $33.45 with minimal daily movement (+0.09%), reflecting subdued momentum amid bearish technical signals. The ETF faces significant technical headwinds with 17 sell signals versus 1 buy, though oscillators remain neutral. Recent news highlights China's mixed economic signals, including strong export growth but persistent overcapacity concerns. The Trump-Xi summit in September 2026 offered limited progress on trade tensions, maintaining geopolitical uncertainty for Chinese equities.
FXI presents a value opportunity with a P/E ratio of 11.10—half the S&P 500's valuation—and a 1.98% yield, but faces substantial risks from China's economic rebalancing, weak domestic consumption, and potential export controls. Investor sentiment is cautious due to political and macroeconomic headwinds, though some analysts see long-term potential if China stabilizes growth.
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
